Literature DB >> 23651132

Differentiated thyroid carcinomas and their B7H1 shield.

Lucas Leite Cunha1, Marjory Alana Marcello, José Vassallo, Laura Sterian Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23651132     DOI： 10.2217/fon.13.89

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  6 in total

1.  Expression of B7 Homolog 1 (B7H1) Is Associated with Clinicopathologic Features in Urothelial Bladder Cancer.

Authors:  Qingyuan Li; Feng Li; Jizhong Che; Yang Zhao; Chengjian Qiao
Journal:  Med Sci Monit       Date:  2018-10-13

2.  PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells.

Authors:  Federica Liotti; Narender Kumar; Nella Prevete; Maria Marotta; Daniela Sorriento; Caterina Ieranò; Andrea Ronchi; Federica Zito Marino; Sonia Moretti; Renato Colella; Efiso Puxeddu; Simona Paladino; Yoshihito Kano; Michael Ohh; Stefania Scala; Rosa Marina Melillo
Journal:  J Exp Clin Cancer Res       Date:  2021-01-07

3.  Receptor-ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing.

Authors:  Zhe Xu Cao; Xin Weng; Jiang Sheng Huang; Xia Long
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

4.  The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status.

Authors:  Lucas Leite Cunha; Guilherme Augusto Barcelos Domingues; Elaine Cristina Morari; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  Cancer Cell Int       Date:  2021-07-20       Impact factor: 5.722

5.  The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells.

Authors:  Bo Yuan Huang; Yi Ping Zhan; Wen Jing Zong; Chun Jiang Yu; Jun Fa Li; Yan Ming Qu; Song Han
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

6.  Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer.

Authors:  Eran Brauner; Viswanath Gunda; Pierre Vanden Borre; David Zurakowski; Yon Seon Kim; Kate Virginia Dennett; Salma Amin; Gordon James Freeman; Sareh Parangi
Journal:  Oncotarget       Date:  2016-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.